📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mechanisms of checkpoint inhibition-induced adverse events. (2020)

First Author: Urwyler P

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cei.13421

PubMed Identifier: 31989585

Publication URI: http://europepmc.org/abstract/MED/31989585

Type: Journal Article/Review

Volume: 200

Parent Publication: Clinical and experimental immunology

Issue: 2

ISSN: 0009-9104